查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555617

薄膜式氧供给设备的全球市场:产业分析，规模，占有率，成长，趋势，预测(2024～2032年)

Membrane Oxygenators Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告发表了对全球膜供氧市场的深入研究，并对关键市场动态进行了广泛分析，包括市场推动因素、趋势、机会和课题。该报告提供了对市场结构和未来轨蹟的详细见解。

主要的洞察

  • 薄膜供氧装置市场规模（2024年）：1.421亿美元
  • 市场预测金额（2033 年）：1.66 亿美元
  • 全球市场成长率（2024-2033 年复合年增长率）：2.0%

膜式供氧装置市场：调查范围

膜氧合装置由于能够增强呼吸衰竭患者的气体交换而越来越多地用于重症监护和心臟手术。这些设备在体外生命支持 (ECLS) 和体外膜氧合 (ECMO) 系统中发挥关键作用，这使得它们在医疗保健环境中至关重要。该市场的主要驱动力是呼吸系统疾病和心臟病患病率的上升、对 ECMO 手术的需求不断增加以及各地区医疗基础设施的进步。

市场推动因素：

全球膜氧合设备市场受到几个关键因素的推动。其中包括慢性呼吸系统疾病和心血管疾病的盛行率增加，需要使用先进的氧气输送系统。此外，人们越来越接受 ECMO 作为重症监护环境中的救生干预措施，也对市场成长做出了重大贡献。膜氧合装置设计的技术进步以及这些系统在新生儿和儿科医学中的日益采用也支持了市场的扩张。

市场阻碍因素：

儘管成长前景广阔，但膜氧供应市场仍面临一定的课题。 ECMO 程序和设备相关的高成本可能会阻碍其广泛使用，特别是在发展中国家。此外，这些系统很复杂，需要专门的医务人员来操作，造成了市场进入障碍。对 ECMO 及其在某些地区的应用的认识不足也限制了市场的成长。

市场机会：

由于持续的技术创新和 ECMO 系统在各种医疗保健环境中的使用不断增加，膜氧合设备市场提供了巨大的成长机会。便携式、用户友好的氧气输送设备的开发预计将增加这些设备在紧急情况和家庭护理环境中的可及性。此外，越来越注重透过先进的医疗干预措施改善患者的治疗结果，这为市场成长开闢了新的途径，特别是在医疗基础设施不断发展的新兴市场。

本报告涵盖的主要问题

  • 推动全球膜氧供应市场的关键因素是什么？
  • 哪里对膜式供氧装置的需求量最大？
  • 技术进步如何影响膜氧供应市场？
  • 谁是膜供氧市场的主要参与者？
  • 膜式供氧装置市场的新趋势与未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场背景

  • 市场动态
  • 情势预测
  • 法规情形

第4章 全球薄膜式氧供给设备市场分析

  • 过去的市场规模金额(100万美元)分析，2019～2023年
  • 现在及未来市场规模金额(100万美元)预测，2024～2032年
    • 与前一年同期比较成长趋势分析
    • 绝对的商机

第5章 全球薄膜式氧供给设备市场分析:各产品类型

  • 简介/主要调查结果
  • 过去的市场规模金额(100万美元)分析，各产品类型，2019～2023年
  • 现在及未来市场规模金额(100万美元)分析与预测，各产品类型，2024～2032年
    • 中空纤维滤膜氧供给设备
    • 片状滤膜氧供给设备
  • 与前一年同期比较成长趋势分析，各产品类型，2019～2023年
  • 绝对的商机，各产品类型，2024～2032年

第6章 全球薄膜式氧供给设备市场分析:各年龄层

  • 简介/主要调查结果
  • 过去的市场规模金额(100万美元)分析，各年龄层，2019～2023年
  • 现在及未来市场规模金额(100万美元)分析与预测，各年龄层，2024～2032年
    • 新生儿
    • 儿童
    • 大人
  • 与前一年同期比较成长趋势分析，各年龄层，2019～2023年
  • 绝对的商机，各年龄层，2024～2032年

第7章 全球薄膜式氧供给设备市场分析:各用途

  • 简介/主要调查结果
  • 过去的市场规模金额(100万美元)分析，各用途，2019～2023年
  • 现在及未来市场规模金额(100万美元)分析与预测，各用途，2024～2032年
    • 呼吸系统
      • 呼吸不全
      • 肺动脉栓塞
      • 急性呼吸促拍症候群
      • 肺炎
      • COVID-19
    • 心臟
      • 急性心肌梗塞
      • 心肌炎
      • 移植后併发症
      • 非补偿性心肌病
      • 心源性休克
    • ECPR
  • 与前一年同期比较成长趋势分析，各用途，2019～2023年
  • 绝对的商机，各用途，2024～2032年

第8章 全球薄膜式氧供给设备市场分析:各地区

  • 简介/主要调查结果
  • 过去的市场规模金额(100万美元)分析，各地区，2019～2023年
  • 现在及未来市场规模金额(100万美元)分析与预测，各地区，2024～2032年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东·非洲
  • 市场魅力分析:各地区

第9章 北美的薄膜式氧供给设备市场分析:各国

第10章 南美的薄膜式氧供给设备市场分析:各国

第11章 欧洲的薄膜式氧供给设备市场分析:各国

第12章 东亚的薄膜式氧供给设备市场分析:各国

第13章 南亚的薄膜式氧供给设备市场分析:各国

第14章 大洋洲的薄膜式氧供给设备市场分析:各国

第15章 中东·非洲的薄膜式氧供给设备市场分析:各国

第16章 主要国家的薄膜式氧供给设备市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 阿根廷
  • 德国
  • 义大利
  • 法国
  • 英国
  • 西班牙
  • 俄罗斯
  • 荷比卢三国
  • 中国
  • 日本
  • 韩国
  • 印度
  • 泰国
  • 马来西亚
  • 印尼
  • 澳洲
  • 纽西兰
  • GCC各国

第17章 市场结构分析

  • 竞争仪表板
  • 竞争基准
  • 主要企业的市场占有率分析

第18章 竞争分析

  • 竞争详细内容
    • MicroPort Scientific Corporation
    • Nipro Medical Corporation
    • Medtronic
    • Fresenius SE &Co KGaA
    • Terumo Medical Corporation
    • Getinge AB

第19章 所使用的假设和缩写

第20章 调查手法

简介目录
Product Code: PMRREP33254

Persistence Market Research has recently published a detailed report on the global Membrane Oxygenators Market, offering an extensive analysis of key market dynamics, including drivers, trends, opportunities, and challenges. The report presents in-depth insights into the structure of the market and its future trajectory.

Key Insights:

  • Membrane Oxygenators Market Size (2024E): USD 142.1 Mn
  • Projected Market Value (2033F): USD 166 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 2.0%

Membrane Oxygenators Market - Report Scope:

Membrane oxygenators are increasingly being used in critical care and cardiac surgeries due to their ability to facilitate gas exchange for patients with respiratory failure. These devices play a vital role in extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) systems, making them indispensable in healthcare settings. The market is primarily driven by the rising incidence of respiratory and cardiac disorders, the growing demand for ECMO procedures, and advancements in healthcare infrastructure across various regions.

Market Growth Drivers:

The global membrane oxygenators market is fueled by several important factors. These include the increasing prevalence of chronic respiratory and cardiovascular diseases, which necessitate the use of advanced oxygenation systems. Additionally, the growing acceptance of ECMO as a lifesaving intervention in critical care settings is a major contributor to market growth. Technological advancements in membrane oxygenator design and the rising adoption of these systems in neonatal and pediatric care further support market expansion.

Market Restraints:

Despite its promising growth prospects, the membrane oxygenators market faces certain challenges. High costs associated with ECMO procedures and devices can hinder their widespread adoption, particularly in developing countries. Furthermore, the complexity of these systems and the need for specialized healthcare professionals to operate them add to the barriers to market entry. Limited awareness about ECMO and its applications in certain regions also restricts market growth.

Market Opportunities:

The membrane oxygenators market presents significant growth opportunities driven by ongoing technological innovations and the expanding use of ECMO systems across various healthcare settings. The development of portable and user-friendly oxygenators is expected to increase the accessibility of these devices in emergency and home care settings. Moreover, the rising focus on improving patient outcomes through advanced medical interventions opens up new avenues for market growth, particularly in emerging markets where healthcare infrastructure is evolving.

Key Questions Answered in the Report:

  • What are the main factors driving the global membrane oxygenators market?
  • Which regions are witnessing the highest demand for membrane oxygenators?
  • How are technological advancements impacting the membrane oxygenators market?
  • Who are the leading players in the membrane oxygenators market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the membrane oxygenators market?

Competitive Intelligence and Business Strategy:

Leading players in the global membrane oxygenators market, such as Medtronic, Terumo Cardiovascular Systems, and Getinge AB, are focusing on innovation, product development, and strategic partnerships to stay competitive. These companies are investing in research and development to enhance device efficiency, improve patient outcomes, and expand their product portfolios. Collaborations with healthcare institutions and the introduction of cost-effective solutions for critical care are key strategies driving market growth. Additionally, meeting stringent regulatory requirements and maintaining high product quality remain priorities for companies in this space, ensuring sustained growth in the global membrane oxygenators market.

Key Companies Profiled:

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB

Market Segments Covered in Membrane Oxygenators Market Analysis

By Type

  • Hollow Fiber Membrane Oxygenators
  • Flat Sheet Membrane Oxygenators

By Age Group

  • Neonates
  • Pediatrics
  • Adults

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Regulatory Landscape
    • 3.3.1. By Key Regions
    • 3.3.2. By Key Countries

4. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2024-2032
    • 5.3.1. Hollow Fiber Membrane Oxygenators
    • 5.3.2. Flat Sheet Membrane Oxygenators
  • 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Age Group, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group, 2024-2032
    • 6.3.1. Neonates
    • 6.3.2. Pediatrics
    • 6.3.3. Adults
  • 6.4. Y-o-Y Growth Trend Analysis By Age Group, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Age Group, 2024-2032

7. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 7.3.1. Respiratory
      • 7.3.1.1. Respiratory failure
      • 7.3.1.2. Pulmonary embolism
      • 7.3.1.3. Acute respiratory distress syndrome
      • 7.3.1.4. Pneumonia
      • 7.3.1.5. COVID-19
    • 7.3.2. Cardiac
      • 7.3.2.1. Acute myocardial infarction
      • 7.3.2.2. Myocarditis
      • 7.3.2.3. Post-transplant complications
      • 7.3.2.4. Decompensated cardiomyopathy
      • 7.3.2.5. Cardiogenic shock
    • 7.3.3. ECPR
  • 7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application, 2024-2032

8. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. East Asia
    • 8.3.5. South Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Product Type
    • 9.2.3. By Age Group
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Age Group
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Argentina
      • 10.2.1.4. Rest of Latin America
    • 10.2.2. By Product Type
    • 10.2.3. By Age Group
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Age Group
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. BENELUX
      • 11.2.1.8. Rest of Europe
    • 11.2.2. By Product Type
    • 11.2.3. By Age Group
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Age Group
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. East Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
    • 12.2.2. By Product Type
    • 12.2.3. By Age Group
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Age Group
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. South Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Thailand
      • 13.2.1.3. Malaysia
      • 13.2.1.4. Indonesia
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product Type
    • 13.2.3. By Age Group
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product Type
    • 13.3.3. By Age Group
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Product Type
    • 14.2.3. By Age Group
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product Type
    • 14.3.3. By Age Group
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. GCC
      • 15.2.1.2. Rest of MEA
    • 15.2.2. By Product Type
    • 15.2.3. By Age Group
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product Type
    • 15.3.3. By Age Group
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Membrane Oxygenators Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2024
      • 16.1.2.1. By Product Type
      • 16.1.2.2. By Age Group
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2024
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By Age Group
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2024
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By Age Group
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2024
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By Age Group
      • 16.4.2.3. By Application
  • 16.5. Argentina
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2024
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By Age Group
      • 16.5.2.3. By Application
  • 16.6. Germany
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2024
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By Age Group
      • 16.6.2.3. By Application
  • 16.7. Italy
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2024
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By Age Group
      • 16.7.2.3. By Application
  • 16.8. France
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2024
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By Age Group
      • 16.8.2.3. By Application
  • 16.9. U.K.
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2024
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By Age Group
      • 16.9.2.3. By Application
  • 16.10. Spain
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2024
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By Age Group
      • 16.10.2.3. By Application
  • 16.11. Russia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2024
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By Age Group
      • 16.11.2.3. By Application
  • 16.12. BENELUX
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2024
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By Age Group
      • 16.12.2.3. By Application
  • 16.13. China
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2024
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By Age Group
      • 16.13.2.3. By Application
  • 16.14. Japan
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2024
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By Age Group
      • 16.14.2.3. By Application
  • 16.15. South Korea
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2024
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By Age Group
      • 16.15.2.3. By Application
  • 16.16. India
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2024
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By Age Group
      • 16.16.2.3. By Application
  • 16.17. Thailand
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2024
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By Age Group
      • 16.17.2.3. By Application
  • 16.18. Malaysia
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2024
      • 16.18.2.1. By Product Type
      • 16.18.2.2. By Age Group
      • 16.18.2.3. By Application
  • 16.19. Indonesia
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2024
      • 16.19.2.1. By Product Type
      • 16.19.2.2. By Age Group
      • 16.19.2.3. By Application
  • 16.20. Australia
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2024
      • 16.20.2.1. By Product Type
      • 16.20.2.2. By Age Group
      • 16.20.2.3. By Application
  • 16.21. New Zealand
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2024
      • 16.21.2.1. By Product Type
      • 16.21.2.2. By Age Group
      • 16.21.2.3. By Application
  • 16.22. GCC Countries
    • 16.22.1. Pricing Analysis
    • 16.22.2. Market Share Analysis, 2024
      • 16.22.2.1. By Product Type
      • 16.22.2.2. By Age Group
      • 16.22.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Product Type
    • 17.3.3. By Age Group
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. MicroPort Scientific Corporation
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
        • 18.1.1.5.2. Product Strategy
        • 18.1.1.5.3. Channel Strategy
    • 18.1.2. Nipro Medical Corporation
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
        • 18.1.2.5.2. Product Strategy
        • 18.1.2.5.3. Channel Strategy
    • 18.1.3. Medtronic
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
        • 18.1.3.5.2. Product Strategy
        • 18.1.3.5.3. Channel Strategy
    • 18.1.4. Fresenius SE & Co KGaA
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
        • 18.1.4.5.2. Product Strategy
        • 18.1.4.5.3. Channel Strategy
    • 18.1.5. Terumo Medical Corporation
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
        • 18.1.5.5.2. Product Strategy
        • 18.1.5.5.3. Channel Strategy
    • 18.1.6. Getinge AB
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
        • 18.1.6.5.2. Product Strategy
        • 18.1.6.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology